Surgeon and women’s cancers expert Leslie R. Boyd, MD, has been named Director of the Division of Gynecologic Oncology at the Laura and Isaac Perlmutter Cancer Center and within the Department of Obstetrics and Gynecology at New York University (NYU) Langone Health.
Dr. Boyd joined NYU Langone in 2009 and serves as Associate Professor in the Department of Obstetrics and Gynecology and Director of the Gynecologic Oncology Fellowship Program. During her tenure, she has led various initiatives in gynecologic surgery, creating complex surgical plans to remove extensive ovarian, cervical, or endometrial cancer and specializing in robotic-assisted minimally invasive surgery.
Dr. Boyd has an exceptional record of patient outcomes as well as a history of leadership and expertise in investigating best practices and outcomes in gynecologic surgery, identifying disparities in care for patients with gynecologic cancer, and investigating novel chemotherapy options for gynecologic cancers.
Leslie R. Boyd, MD
In her new role, Dr. Boyd plans to continue to advance excellence in patient care, strengthen its research arch, and foster further expansion of clinical trials within the gynecologic oncology space. She is also committed to ensuring that the division continues to meet the needs of the diverse population of New York City and the tristate area.
Education and Experience
After graduating from Harvard University, Dr. Boyd completed medical school at Yale School of Medicine. She joined NYU Grossman School of Medicine for both her residency in obstetrics/gynecology and her fellowship in gynecologic oncology.
A researcher and educator, Dr. Boyd has authored or coauthored more than 70 peer-reviewed publications and abstracts. She has presented at numerous national conferences and is also a member of several prestigious medical societies, including ASCO, and she serves as Chair of the Physician Payment Reform Taskforce for the Society of Gynecologic Oncology. Dr. Boyd advocates for novel payment systems to incentivize quality and safety in cancer care delivery.